01-11-2017 | Case report
Tubulointerstitial nephritis as adverse effect of programmed cell death 1 inhibitor, nivolumab, showed distinct histological findings
Published in: CEN Case Reports | Issue 2/2017
Login to get access01-11-2017 | Case report
Published in: CEN Case Reports | Issue 2/2017
Login to get access